Phibro Animal Health (NASDAQ:PAHC) Upgraded to “Buy” at StockNews.com

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a hold rating to a buy rating in a research report sent to investors on Saturday morning.

Several other research analysts have also recently issued reports on the stock. Barclays increased their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus target price of $21.00.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $21.85 on Friday. The stock has a market cap of $884.99 million, a P/E ratio of 45.52, a P/E/G ratio of 0.45 and a beta of 0.58. Phibro Animal Health has a twelve month low of $12.07 and a twelve month high of $26.55. The stock has a 50 day moving average of $22.60 and a two-hundred day moving average of $22.59. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, research analysts forecast that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.20%. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Institutional Investors Weigh In On Phibro Animal Health

Several institutional investors and hedge funds have recently made changes to their positions in PAHC. Thrivent Financial for Lutherans increased its holdings in Phibro Animal Health by 23.1% during the 3rd quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company’s stock valued at $468,000 after acquiring an additional 3,907 shares in the last quarter. Segall Bryant & Hamill LLC increased its stake in shares of Phibro Animal Health by 1.7% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company’s stock worth $3,931,000 after purchasing an additional 2,971 shares in the last quarter. Algert Global LLC raised its position in shares of Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after purchasing an additional 59,850 shares during the last quarter. FMR LLC lifted its stake in Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after buying an additional 7,270 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in Phibro Animal Health during the 3rd quarter valued at $70,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.